BUREN advises Synergy Health Ede B.V., a STERIS company, in the sale of the pharmaceutical testing services business of Synergy Health Utrecht B.V., a STERIS company, to CCR Group, part of FIELDS Group.
The transaction includes the chemical testing laboratory in Utrecht and the microbiological testing for pharmaceuticals in Ede, the Netherlands. STERIS will continue to operate the laboratory in Ede with a focus on medical device testing.
STERIS is a NYSE listed leading provider of infection prevention and other procedural products and services. The company is focused primarily on healthcare, pharmaceutical and medical device customers. Steris has approximately 13,000 associates worldwide and operates in more than 100 countries.
CCR Group is a European CRO with laboratory sites in Germany and the Netherlands offering a comprehensive set of integrated services to predominantly the pharmaceutical and biotech industries.
Friederike Henke, lawyer at BUREN, wrote two papers about corporate accountability in a changing business world. The papers outline the framework the Netherlands
The year in which the COVID-19 pandemic had the entire world in its grip also became the year in which a hard Brexit was prevented at the last minute.
The effects of the Corona-crisis shall reiterate long time after the virus shall have been beat. Both sellers and purchasers better prepare for that